Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi ArabiaRelease Date:Research Vaccines Saudi Arabia Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing EquityRelease Date:Education Inflammation & Immunology Australia Improving Precision Oncology Care Through Molecular Diagnostic Integration and Data Quality ImprovementRelease Date:Quality Improvement Oncology Kazakhstan Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer CareEducation Oncology USA Improving Shared Decision Making in Hemophilia: Visiting Professorship ProgramRelease Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA Improving Metastatic Prostate Cancer (mPCa) Care Through Innovative StrategiesRelease Date:Quality Improvement Oncology All Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology PracticeRelease Date:Education Oncology USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology China, France, Germany, Italy, Japan, Spain, Turkey, United Kingdom Title Grant Type Focus Area Country Application Due Date Pfizer and Global Bridges at Mayo Clinic: Treating Tobacco Dependence- Europe ProgramRelease Date:Implementation of MenB Vaccine Recommendations in Older Adolescents/Young AdultsRelease Date:Rheumatology FellowshipsRelease Date:Release Date:Review Process:IPI and Pfizer: Device Challenge- System for Dosing and Dispensing Multiparticulate Formulations of Pediatric DrugsRelease Date:Pfizer and American Pain Society: Improving Chronic Pain CareRelease Date:Accelerating Improvements in Medication OptimizationRelease Date:Review Process:Haemophilia Early Arthropathy Detection with UltraSound (HEAD-US) Protocol for Routine Joint Assessment of Haemophilia PatientsRelease Date:Improving Care of Patients with Atrial Fibrillation in Order to Reduce Stroke RiskRelease Date:IGLC_IHI_RFP Accelerating Improvements in Medication Optimization_Re-releaseRelease Date:Pfizer and Global Healthy Living Foundation: Rheumatoid Arthritis Shared Decision MakingRelease Date:Review Process:IBD Fellowship RFP 12212016Release Date: